The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
Kulagin, Aleksandr D., Bakirov, Bulat A., Davydkin, Igor L., Elykomov, Ilya V., Konstantinova, Tatiana S., Korobkin, Aleksandr V., Kosinova, Marina V., Mazurov, Vadim I., Minaeva, Natalia V., Proidakov, Andrei V., Ptushkin, Vadim V., Shatokhin, Yuri V., Lin'kova, Yulia N., Zinkina-Orikhan, Arina V., Morozova, Maria A.
Published in Terapevtic̆eskii arhiv (15.11.2021)
Published in Terapevtic̆eskii arhiv (15.11.2021)
Get full text
Journal Article